Announced Mon, 10 Aug · 12:27 IST
Kwality Pharma Q1 FY27: revenue up 46% YoY, PAT up 115%, margins expand
Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+27.5%1-day move
₹2615.00
prior close
₹3117.60
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.5+0.5+0.5+27.5+27.2+26.8+30.0+38.4+32.8————
Up moveDown movePending
AI summary
Consolidated Q1FY27 revenue rose 46% YoY to Rs 162.35 crore from Rs 111.48 crore. EBITDA grew to Rs 41 crore with margins expanding from 21.9% to 25.3%. PAT surged 115% YoY to Rs 25.62 crore; EPS at Rs 24.70 vs Rs 11.50. Management raised FY27 guidance: revenue 700+ crore, PAT 109+ crore. Completed 13 bioequivalence studies and 15+ new registrations in Malaysia, Algeria, Peru and Mexico.
Likely market impact
Strong Q1 results, margin expansion and raised FY27 guidance signal positive earnings momentum for shareholders.